← Back to Clinical Trials
Recruiting NCT05539105

NCT05539105 A Prospective Observation Registry Study on the Alimentary Reconstruction After Radical Proximal Gastrectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05539105
Status Recruiting
Phase
Sponsor Shanghai Zhongshan Hospital
Condition Proximal Gastric Adenocarcinoma
Study Type OBSERVATIONAL
Enrollment 600 participants
Start Date 2022-08-22
Primary Completion 2027-12-31

Trial Parameters

Condition Proximal Gastric Adenocarcinoma
Sponsor Shanghai Zhongshan Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2022-08-22
Completion 2027-12-31
Interventions
Double tract reconstructionGastric conduit reconstructionOther reconstructions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is designed as a prospective, real world registry study that compare the safety and efficacy of the different construction methods after radical proximal gastrectomy.

Eligibility Criteria

Inclusion Criteria: * Aged 18-80 years * Tumor located in the upper or esophagogastric junction (EGJ), and curative resection with more than 1/2 remant is expected to be achievable by proximal gastrectomy with D2 lymphadenectomy (also apply to multiple primary cancers); * Clinical stage T1NxM0 (According to AJCC-8th TNM staging system) of the upper stomach or diameter of EGJ cancer less than 4cm with invading esophgus no more than 2cm without any distant metastasis; * Primary lesion is pathologically diagnosed as gastric adenocarcinoma, such as papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, poorly cohesive carcinoma (including signet ring cell carcinoma and other variants), and mixed adenocarcinoma; * Preoperative performance status (ECOG,Eastern Cooperative Oncology Group) of 0 or 1 * Preoperative ASA (American Society of Anesthesiologists) scoring: I-III * Sufficient organ functions * Written informed consent Exclusion Criteria: \-

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology